What's breaking now, across thousands of outlets.
First-time homebuyers are not only historically old but also increasingly reliant on family wealth.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
Plus news about Rezera, ANI Pharmaceuticals, Cloudbreak Pharma and Anaheim Bio. RevMed’s stock jumps on early Rasonque sales: The RAS drug developer reported sales of its pancreatic cancer therapy…
Sequential revenue jumped 77% while cash losses shrank sharply.
Is Greg Abel just getting started, or is this his acquisition approach for the post-Buffett era?
In a significant, albeit underreported development for global energy, and for the US-Iran standoff in the Persian Gulf, the Iranian parliament has this week announced it is exempting several key…